print
email
 
   

 

 

 

 

About Us > Our Team > Board of Directors

     
Jai Hiremath, Chairman and Managing Director
Jai Hiremath is the Chairman and Managing Director of Hikal Ltd. A Chartered Accountant from England and Wales, he has completed the Advanced Management Program for professionals and entrepreneurs from Harvard University, USA in 2004. He has more than 35 years of experience in the chemical and pharmaceutical industry. Mr. Hiremath established the company in 1988 and under his leadership; Hikal has grown to become one of leading life sciences companies globally.
Mr. Hiremath is the Past President of the Indian Chemical Council (ICC) and the former Chairman of the Chemical Committee of the Federation of Indian Chamber of Commerce and Industry (FICCI). Mr. Hiremath is also a board member of Novartis (India) Ltd and National Safety Council (NSC) of India. Most recently he has been elected to serve as a board member of DCAT (Drug, Chemical and Associated Technology Association) headquartered in New Jersey, U.S.A.
 
     
Sameer Hiremath, President and Joint Managing Director
Sameer Hiremath is the President & Joint Managing Director of Hikal Ltd. His responsibilities include overseeing the day to day operations of the company. Mr. Hiremath did his Chemical Engineering from MIT (Maharashtra Institute of Technology), Pune and an MBA cum M.S. degree in Information Technology from Boston University, USA. Over the years, he has held various positions at Hikal including that of Executive Director. He has over 16 years of experience in plant operations and manufacturing at Hikal.
 
     
Baba Kalyani, Board Member
Baba Kalyani is the Chairman and Managing Director of Bharat Forge Ltd. Mr. Kalyani is an M.E. from Birla Institute of Technology & Sciences, Pilani and an M.S. from Massachusetts Institute of Technology, USA. Mr. Kalyani has been awarded CEO of the year 2004 by Business Standard, Entrepreneur of the Year (Manufacturing) 2005 by Ernst & Young and Businessman of the Year 2006 by Business India Magazine. He has been honored by the Government of India which conferred the Padma Bhushan on Mr. Kalyani in 2008 and by the French Government which honored him with the distinction, Chevalier l'Ordre de la Legion d'Honneur (Knight of the National Order) in 2011 in recognition of his important contribution to enhance relations between India and France in the economic and commercial fields.
 
     
Kannan Unni, Board Member
Kannan Unni, graduated in agriculture from Mumbai University and holds Diploma in marketing from Mumbai University He is a pioneer in crop protection and increasing the farm yield in India. Mr. Unni was the Chairman of Bilag Industries Pvt. Ltd., a 100% subsidiary of Bayer CropScience. Prior to that Mr. Unni was the CEO of Aventis CropScience in India. He brings a wealth of experience in technology and marketing in the crop protection industry.
 
     
Dr. Peter Pollak, Board Member
Dr. Peter Pollak is a Ph.D. in Chemistry from the Swiss Federal Institute of Technology, Zurich. He is internationally recognized as a pioneer in the development of the modern fine chemicals industry. He has more than 38 years of experience in fine chemicals, notably at Lonza in Switzerland and U.S.A. He has published numerous articles in several prestigious chemical publications worldwide. He is consultant to some of the world's leading fine chemical and pharmaceutical companies and has recently published the second edition of his book 'Fine Chemicals, the Industry and the Business'.
 
     
Prakash Mehta, Board Member
Prakash Mehta graduated in law from University of Bombay in 1963. He has extensive experience in corporate law both in India and overseas. Mr. Mehta is on the boards of several conglomerates and is a member of the Managing Committee of The Bombay Incorporated Law Society. He is a senior partner at M/s. Malvi Ranchoddas & Co., Advocates & Solicitors, one of the leading law firms in Mumbai.
 
     

Shivkumar Kheny,
Board Member
Shivkumar Kheny has extensive industry experience, specifically in steel and infrastructure development. Mr. Kheny sits on the board of several reputable companies some of which are listed on the Bombay Stock Exchange.
 
     
Sugandha Hiremath, Board Member
Sugandha Hiremath has more than 25 years experience in finance. She serves as an independent director on the board of several companies.
 
     
Dr. Wolfgang Welter, Board Member
Dr. Wolfgang Welter, Board Member Dr. Wolfgang Welter started his career in 1977 at Hoechst AG where he held a number of senior positions in Crop Protection and Fine Chemicals divisions. He served as the Head of Production at AgrEvo after which he took on the role of overseeing manufacturing operations at Aventis CropScience in France. Prior to his retirement, Dr. Welter was the Head of Industrial Operations at Bayer CropScience AG. He has served the industry for more than 30 years and brings a wealth of experience to Hikal.
 
     
Amit Kalyani, Director
Amit Kalyani received his Bachelor's in Mechanical Engineering from Bucknell University, Pennsylvania, USA, in 1998. He is currently an Executive Director on the board of Bharat Forge Limited, the flagship company of the US $ 2.4 billion Kalyani Group. He is involved in the company's strategic planning & global business development initiatives and he also oversees the entire group's strategy. He serves on the Boards of several companies.
 
     
Prof Axel Kleemann
Professor Axel Kleemann holds a Ph.D. in Chemistry from the Johann Wolfgang Goethe University, Frankfurt am Main, where he is the Honorary Professor of Chemistry. Prof. Kleemann was a member of the Management Board of ASTA Medica AG from 1987 to 2000. He was responsible for research and development, production, engineering and drug safety. Apart from being a board member in various organizations and scientific societies in Germany, Prof. Kleemann is also the Chairman of the Board of Directors of Protagen AG and a member of the Board of Directors of several non-listed and listed biotech and fine chemical companies.
Prof. Kleemann is the co-author of the standard reference book, 'Pharmaceutical Substances'.
 
     
     
Top